Xiangwu Zheng

Xiangwu Zheng


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2007 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
XZXiangwu Zheng
Xiangwu Zheng
JCJianmin Cheng
Jianmin Cheng
KPKehua Pan
Kehua Pan
KYKaiyan Yang
Kaiyan Yang
HWHongqing Wang
Hongqing Wang
EWEnfu Wu
Enfu Wu

10 November 2020 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
JHJun-Jie Hong
Jun-Jie Hong
BLBo-Le Liu
Bo-Le Liu
ZWZhi-Qiang Wang
Zhi-Qiang Wang
KTKun Tang
Kun Tang
XJXiao-Wei Ji
Xiao-Wei Ji
XZXiangwu Zheng
Xiangwu Zheng
Background: Clinical management decisions on prostate cancer (PCa) are often based on a determination of risk. 68Ga-prostate-specific membrane antigen (PSMA)-11-positron emission tomography (PET)/computer tomography (CT) is an attractive modality to assess biochemical recurrence of PCa, detect metastatic disease and stage of primary PCa, making it a promising strategy for risk stratification. However, due to some limitation of 68Ga-PSMA-11 the development of alternative tracers is of high interest. In this study, we aimed to investigate the value of 18F-PSMA-1007 in identifying non-metastatic high-risk PCa. Methods: A total of 101 patients with primary non-metastatic PCa who underwent 18F-PSMA-1007 PET/CT were retrospectively analyzed. According to the European Association of Urology guidelines on PCa, patients were classified into intermediate-risk (IR) group or high-risk (HR) group. The maximum standardized uptake values (SUVmax) of the primary prostate tumor were measured on PET/CT images. The diagnostic performance of PET/CT for IR and HR PCa was calculated, and the relationship between the SUVmax of primary prostate tumor, prostate-specific antigen (PSA) level and Gleason score (GS) was analyzed. Results: Of all 101 patients, 49 patients were classified into IR group and 52 patients were classified into HR group. There was a significant positive correlation between PSA level/GS and SUVmax (r = 0.561, r = 0.496, P < 0.001, respectively). Tumors with GS 6 and 7a showed significantly lower 18F-PSMA-1007 uptake compared to patients with GS 8 and 9 (P < 0.01). SUVmax in patients of HR was significantly higher than those of IR (median SUVmax: 16.85 vs 7.80; P < 0.001). In receiver operating characteristic curve analysis, the optimal cutoff value of the SUVmax for identifying high-risk PCa was set as 9.05 (area under the curve: 0.829; sensitivity: 90.4%; specificity: 65.3%). Conclusion: 18F-PSMA-1007 PET/CT showed the powerful diagnosis efficacy for high-risk PCa, which can be used as an objective imaging reference index for clinical reference.

26 October 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
BXBeihui Xue
Beihui Xue
JJJia Jiang
Jia Jiang
LCLei Chen
Lei Chen
SWSunjie Wu
Sunjie Wu
XZXuan Zheng
Xuan Zheng
KTKun Tang
Kun Tang
Objectives: The aim of this study was to develop a preoperative positron emission tomography (PET)-based radiomics model for predicting peritoneal metastasis (PM) of gastric cancer (GC).Methods: In this study, a total of 355 patients (109PM+, 246PM-) who underwent preoperative fluorine-18-fludeoxyglucose (18F-FDG) PET images were retrospectively analyzed. According to a 7:3 ratio, patients were randomly divided into a training set and a validation set. Radiomics features and metabolic parameters data were extracted from PET images. The radiomics features were selected by logistic regression after using maximum relevance and minimum redundancy (mRMR) and the least shrinkage and selection operator (LASSO) method. The radiomics models were based on the rest of these features. The performance of the models was determined by their discrimination, calibration, and clinical usefulness in the training and validation sets.Results: After dimensionality reduction, 12 radiomics feature parameters were obtained to construct radiomics signatures. According to the results of the multivariate logistic regression analysis, only carbohydrate antigen 125 (CA125), maximum standardized uptake value (SUVmax), and the radiomics signature showed statistically significant differences between patients (P<0.05). A radiomics model was developed based on the logistic analyses with an AUC of 0.86 in the training cohort and 0.87 in the validation cohort. The clinical prediction model based on CA125 and SUVmax was 0.76 in the training set and 0.69 in the validation set. The comprehensive model, which contained a rad-score and the clinical factor (CA125) as well as the metabolic parameter (SUVmax), showed promising performance with an AUC of 0.90 in the training cohort and 0.88 in the validation cohort, respectively. The calibration curve showed the actual rate of the nomogram-predicted probability of peritoneal metastasis. Decision curve analysis (DCA) also demonstrated the good clinical utility of the radiomics nomogram.Conclusions: The comprehensive model based on the rad-score and other factors (SUVmax, CA125) can provide a novel tool for predicting peritoneal metastasis of gastric cancer patients preoperatively.

1 January 2021 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
LWLili Wang
Lili Wang
TLTiancheng Li
Tiancheng Li
JHJunjie Hong
Junjie Hong
MZMingyue Zhang
Mingyue Zhang
MOMingli Ouyang
Mingli Ouyang
KTKun Tang
Kun Tang
Background: This study aimed to develop a preoperative positron emission tomography (PET)-based radiomics model for predicting occult lymph node metastasis (OLM) in clinical N0 (cN0) solid lung adenocarcinoma. Methods: The preoperative fluorine-18-fludeoxyglucose (18F-FDG) PET images of 370 patients with cN0 lung adenocarcinoma confirmed by histopathological examination were retrospectively reviewed. Patients were divided into training and validation sets. Radiomics features and relevant data were extracted from PET images. A nomogram was developed in a training set via univariate and multivariate logistic analyses, and its performance was assessed by concordance-index (C-index), calibration curves, and decision curve analysis (DCA) in the training and validation sets. Results: The multivariate logistic regression analysis showed that only carcinoembryonic antigen (CEA), metabolic tumor volume (MTV), and the radiomics signature had statistically significant differences between patients with and without OLM (P<0.05). A nomogram was developed based on the logistic analyses, and its C-index was 0.769 in the training set and 0.768 in the validation set. The calibration curve demonstrated good consistency between the nomogram-predicted probability of OLM and the actual rate. The DCA also confirmed the clinical utility of the nomogram. Conclusions: A PET/computed tomography (CT)-based radiomics model including CEA, MTV, and the radiomics signature was developed and demonstrated adequate predictive accuracy and clinical net benefit in the present study, and was conveniently used to facilitate the individualized preoperative prediction of OLM.

11 November 2010 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
KTKun Tang
Kun Tang
LWLing Wang
Ling Wang
RSRongfang Shi
Rongfang Shi
XZXiangwu Zheng
Xiangwu Zheng
TLTing Li
Ting Li
RLRuming Lu
Ruming Lu

5 September 2020 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SMShou-Liang Miao
Shou-Liang Miao
XYXiao-Ning Ye
Xiao-Ning Ye
TLTing-Ting Lin
Ting-Ting Lin
YQYi-Hui Qiu
Yi-Hui Qiu
JHJing-Yong Huang
Jing-Yong Huang
FCFanfeng Chen
Fanfeng Chen